Trial Profile
Pharmacokinetic modeling to support dosing of Teduglutide in pediatric patients with short bowel syndrome
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Apr 2017
Price :
$35
*
At a glance
- Drugs Teduglutide (Primary)
- Indications Short bowel syndrome
- Focus Pharmacokinetics
- 08 Apr 2017 New trial record
- 18 Mar 2017 Results presented at the 118th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics